[1]

[2]

SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.

[3]

LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.

[4]

YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.

[5]

XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.

[6]

CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.

[7]

. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.

[8]

. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.

[9]

[10]

YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.

[11]

DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.

[12]

GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.

[13]

. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.

[14]

. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.

[15]

. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

试剂	UA	C3	CHE	RF
R1	663.80	370.47	18.38	0.42
R2	2.05	0.23	0.42	6.84

试剂	UA	C3	CHE	RF
R1	663.80	370.47	18.38	0.42
R2	2.05	0.23	0.42	6.84

项目	测定次数	TBA	UA_R1→TBA	C3_R1→TBA	CHE_R1→TBA	RF_R2→TBA
对照	340	17.88±2.40
特殊清洗前	340		69.93±9.36^**	37.50±6.28^**	27.51±3.20^*	17.94±2.43
特殊清洗后	340		35.32±3.51^*	17.58±2.32	17.78±2.31

项目	测定次数	TBA	UA_R1→TBA	C3_R1→TBA	CHE_R1→TBA	RF_R2→TBA
对照	340	17.88±2.40
特殊清洗前	340		69.93±9.36^**	37.50±6.28^**	27.51±3.20^*	17.94±2.43
特殊清洗后	340		35.32±3.51^*	17.58±2.32	17.78±2.31

RichHTML

PDF (PC)

[1]	丁双双,汪浩,沈霞. HDL-C试剂干扰血清总胆汁酸测定结果的原因分析及对策[J]. 检验医学,2011,26(3):215-216.
[2]	陈继中,李旭光,唐吉斌. 试剂携带污染对血清总胆汁酸测定结果的影响及消除措施[J]. 检验医学,2006,21(3):228-230.
[3]	赵笔辉. 应用日立7180全自动生化分析仪的检测时序处理交叉污染[J]. 检验医学,2016,31(2):140-143.
[4]	陈彬,邓小军,许永志. 西门子ADVIA2400生化分析仪性能评价[J]. 检验医学与临床,2012,9(21):2739-2741.
[5]	梁耀荣,谢国强. 生化试剂对循环酶法测定血清总胆汁酸的干扰因素分析和改进措施[J]. 现代医院,2012,12(2):64-66.
[6]	王传发. 日立7600生化分析仪检测血清镁中的试剂交叉污染及其消除措施[J]. 检验医学,2010,25(6):465-467.